Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Veracyte (VCYT) Change in Receivables (2016 - 2025)

Historic Change in Receivables for Veracyte (VCYT) over the last 14 years, with Q3 2025 value amounting to -$425000.0.

  • Veracyte's Change in Receivables rose 7485.21% to -$425000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.9 million, marking a year-over-year decrease of 7961.57%. This contributed to the annual value of $6.4 million for FY2024, which is 26478.0% up from last year.
  • Veracyte's Change in Receivables amounted to -$425000.0 in Q3 2025, which was up 7485.21% from -$2.8 million recorded in Q2 2025.
  • Over the past 5 years, Veracyte's Change in Receivables peaked at $7.1 million during Q1 2025, and registered a low of -$3.1 million during Q2 2023.
  • For the 5-year period, Veracyte's Change in Receivables averaged around $1.0 million, with its median value being $763000.0 (2023).
  • Per our database at Business Quant, Veracyte's Change in Receivables surged by 167478.99% in 2021 and then plummeted by 38372.46% in 2023.
  • Over the past 5 years, Veracyte's Change in Receivables (Quarter) stood at $2.3 million in 2021, then tumbled by 93.92% to $139000.0 in 2022, then surged by 448.92% to $763000.0 in 2023, then crashed by 360.94% to -$2.0 million in 2024, then skyrocketed by 78.65% to -$425000.0 in 2025.
  • Its last three reported values are -$425000.0 in Q3 2025, -$2.8 million for Q2 2025, and $7.1 million during Q1 2025.